openPR Logo
Press release

Ulcerative Colitis Treatment Market Expected To Reach $11.1 Billion By 2031 - Abbott Laboratories, Ajinomoto, AstraZeneca Plc., Eli-Lilly, GlaxoSmithKline Plc

11-18-2024 08:17 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Ulcerative Colitis Treatment Market || 2024-2031

Ulcerative Colitis Treatment Market || 2024-2031

The Ulcerative Colitis Treatment Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/ulcerative-colitis-treatment-market

What is the projected growth rate (CAGR) of the Global Ulcerative Colitis Treatment market from 2024 to 2031, and what is the market value expected to change by 2031?

The Global Ulcerative Colitis Treatment Market reached US$ 6.9 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 11.1 billion by 2031. The global ulcerative colitis treatment market is expected to exhibit a CAGR of 6.3% during the forecast period (2024-2031).

Ulcerative colitis treatment involves medical approaches aimed at reducing inflammation, managing symptoms, and promoting long-term remission in individuals with this chronic inflammatory bowel disease. Treatment options include anti-inflammatory drugs, immunosuppressants, biologic therapies (such as monoclonal antibodies), and in severe cases, surgery to remove the colon. The choice of treatment depends on the severity and extent of the disease and individual patient response.

Key Developments:

❁ In October 2022, the National Institute for Health and Care Excellence (NICE) recommended Bristol Myers Squibb's (BMS) Zeposia (ozanimod) for the treatment of adults with moderate-to-severe active ulcerative colitis (UC).

❁ In October 2021, First Wave Biopharma Inc., a clinical-stage biopharmaceutical company, administered the first dose in a Phase 2b clinical trial evaluating a topical formulation of niclosamide (FW-UP) as a potential treatment for ulcerative proctitis (UP) and ulcerative proctosigmoiditis (UPS).

List of the Key Players in the Ulcerative Colitis Treatment Market:

Abbott Laboratories, Ajinomoto, AstraZeneca Plc., Eli-Lilly, GlaxoSmithKline Plc., Index Pharmaceuticals Holdings AB, Johnson & Johnson, Merck & Co., Pfizer Inc., and Sanofi,

Research Process:

Both primary and secondary data sources have been used in the global Ulcerative Colitis Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Ulcerative Colitis Treatment Market:

By Type: Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, Fulminant Colitis

By Drug Class: Immunosuppressant, Anti-Inflammatory Drugs, Anti-TNF biologics, Calcineurin Inhibitors, Others

By Route of Administration: Oral, Injectable

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Regional Breakout:

The global Ulcerative Colitis Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

✫ North America (U.S., Canada, Mexico)

✫ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

✫ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

✫ South America (Colombia, Brazil, Argentina, Rest of South America)

✫ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Get Year End Discounts on Premium Report:- https://www.datamintelligence.com/buy-now-page?report=ulcerative-colitis-treatment-market

This Report Unveils:

✔ Go to Market Strategy- A roadmap to successfully product launch or service in the target market.

✔ Gain a clear picture of the market's health and growth trajectory through neutral analysis.

✔ Deep Market Insights delve into development trends, competitor landscape, supply and demand dynamics, brand share & pricing analysis year-over-year growth patterns, and key players' performance.

✔ Upon request, we can provide customized reports focusing on specific regions or countries, offering a granular view of their markets.

✔ Identify high-potential niche segments and regions poised for significant expansion.

✔ Analysis of Market Size (historical and forecast) Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) to understand the market's overall size and your achievable market share.

✔ Gain a comprehensive understanding of the competitive landscape, including market share distribution, key players (innovators, startups, laggards, and pioneers), and their respective strengths and weaknesses.

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Ulcerative Colitis Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Ulcerative Colitis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the Ulcerative Colitis Treatment market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the Ulcerative Colitis Treatment market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get Customization in the report as per your requirements:- https://datamintelligence.com/customize/ulcerative-colitis-treatment-market

Frequently Asked Questions

☞ What is the expected growth rate of the global Ulcerative Colitis Treatment market for the forecast period?

☞ What are the key driving factors that are responsible to shape the fate of the Ulcerative Colitis Treatment market during the forecast period?

☞ What will be the overall size of the market during the analysis period?

☞ What are the prominent market trends which influence the development of the Ulcerative Colitis Treatment market across various regions?

☞ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☞ What are the challenges and threats that are likely to act as a barrier to the growth of the Ulcerative Colitis Treatment market?

☞ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ulcerative Colitis Treatment Market Expected To Reach $11.1 Billion By 2031 - Abbott Laboratories, Ajinomoto, AstraZeneca Plc., Eli-Lilly, GlaxoSmithKline Plc here

News-ID: 3740085 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Railway Wiring Harness Market | Powering Connectivity in Modern Rail Systems | Top Most Keyplayers - The Furukawa Electric Co Ltd, Leoni AG, Hitachi, Ltd., Nexans S.A, Prysmian Group, TE Connectivity Ltd
Railway Wiring Harness Market | Powering Connectivity in Modern Rail Systems | T …
Railway Wiring Harness Market is estimated to grow at a CAGR of 8.5% during the forecast period 2024-2031 The Railway Wiring Harness Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovative product offerings, competitive pricing strategies, financial performance metrics, strategic growth plans, and
Automotive Infotainment Systems Market | Driving Connected In-Vehicle Experiences | Top Most Keyplayers - Harman International, Bosch, Continental, Denso, Aisin AW
Automotive Infotainment Systems Market | Driving Connected In-Vehicle Experience …
The Global Automotive Infotainment Systems Market is expected to grow at a CAGR of 7.2% during the forecast period (2024-2031). The Automotive Infotainment Systems Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovative product offerings, competitive pricing strategies, financial performance metrics, strategic growth
Automated Ophthalmic Perimeters Market is projected to reach USD 389.52 million by 2033 | iCare, Carl Zeiss, Occulus Inc., Metro Vision, Kowa Company, Essilor Instruments, Optopol Technology, Topcon Corporation
Automated Ophthalmic Perimeters Market is projected to reach USD 389.52 million …
The global automated ophthalmic perimeters market was valued at USD 266.01 million in 2023, rising to USD 276.00 million in 2024. The market is projected to reach USD 389.52 million by 2033, expanding at a compound annual growth rate (CAGR) of 4.7% during the forecast period from 2025 to 2033. The Automated Ophthalmic Perimeters Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and
Automated Ophthalmic Perimeters Market is projected to reach USD 389.52 million by 2033 | iCare, Carl Zeiss, Occulus Inc, Metro Vision, Essilor Instruments, Optopol Technology, Topcon Corporation
Automated Ophthalmic Perimeters Market is projected to reach USD 389.52 million …
The global automated ophthalmic perimeters market was valued at USD 266.01 million in 2023, rising to USD 276.00 million in 2024. The market is projected to reach USD 389.52 million by 2033, expanding at a compound annual growth rate (CAGR) of 4.7% during the forecast period from 2025 to 2033. The Automated Ophthalmic Perimeters Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and

All 5 Releases


More Releases for Colitis

Ulcerative Colitis Market to Reach $4,785 Million by 2023
Advancements in ulcerative colitis treatment modalities has led to the emergence of biologics such as tumor necrosis factors (TNF) in developing drugs. This has led to the shift from traditional therapies towards engineered drugs that has also enhanced the efficacy rate of drugs. According to a new report published by Allied Market Research, titled, Ulcerative Colitis Market by Disease Type, Route of Administration, and Molecule Type: Global Opportunity Analysis and Industry
Ulcerative Colitis Market to Obtain Awesome Hike in Revenues
Global ulcerative colitis market was valued at $4,785 million in 2016, and is expected to reach $7,455 million by 2023, registering a CAGR of 6.5% from 2017 to 2023. The mild ulcerative colitis disease type accounted for nearly half of the market share in 2016. Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/3965 Ulcerative colitis is an inflammatory bowel disease that affects the colon and rectum of the human body. The disease
Ulcerative Colitis Market - Global Industry Analysis, Size, Forecast 2028
Ulcerative Colitis Market “Ulcerative Colitis-Epidemiology Forecasting Intelligence” report provides a comprehensive analysis of the Ulcerative Colitis epidemiology, providing the historical, current, and forecasted data for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan during the period from 2018-2028. Our epidemiology services include: • Incidence and prevalence • Diagnosis rate, treatment rate and mortality patterns • Epidemiology-based forecasting and disease trends • Size of different patient segments in a
Global Ulcerative Colitis Treatment Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on Ulcerative Colitis Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/323101/global-ulcerative-colitis-treatment-market-insights   Anti-inflammatory drugs are often the first
Ulcerative Colitis Market and Forecast Analysis
Boston, MA ReportsWorldwide has announced the addition of a new report title Ulcerative Colitis Market and Forecast Analysis to its growing collection of premium market research reports. Ulcerative colitis is a chronic inflammatory bowel disease that is characterized by inappropriate diffuse inflammation of the rectal and colonic mucosa, which occurs in the innermost layer of the intestinal lining. Ulcerative colitis is a chronic, incurable disease with low mortality that is generally diagnosed
Ulcerative Colitis Market
Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. These disease can affect people of any age, though prevalence is especially high among people under 30 years of age. The major symptoms of this disease are diarrhea, belly pain/cramps, bleeding from the rectum, also other indications are sudden and unexplained